loading
Schlusskurs vom Vortag:
$7.16
Offen:
$7.16
24-Stunden-Volumen:
614.61K
Relative Volume:
0.27
Marktkapitalisierung:
$764.53M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-258.08M
KGV:
-2.6527
EPS:
-2.75
Netto-Cashflow:
$-202.32M
1W Leistung:
+4.66%
1M Leistung:
-3.89%
6M Leistung:
-57.95%
1J Leistung:
-66.61%
1-Tages-Spanne:
Value
$7.0425
$7.3293
1-Wochen-Bereich:
Value
$6.945
$7.50
52-Wochen-Spanne:
Value
$4.55
$26.98

Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile

Name
Firmenname
Rocket Pharmaceuticals Inc
Name
Telefon
646-440-9100
Name
Adresse
350 FIFTH AVENUE, NEW YORK, NY
Name
Mitarbeiter
299
Name
Twitter
@rocketpharma
Name
Nächster Verdiensttermin
2024-11-04
Name
Neueste SEC-Einreichungen
Name
RCKT's Discussions on Twitter

Vergleichen Sie RCKT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
RCKT
Rocket Pharmaceuticals Inc
7.295 764.53M 0 -258.08M -202.32M -2.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
502.17 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.24 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
631.35 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
256.96 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
247.26 24.70B 3.81B -644.79M -669.77M -6.24

Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-12 Eingeleitet BMO Capital Markets Outperform
2024-12-30 Eingeleitet Wedbush Outperform
2024-12-18 Eingeleitet Jefferies Buy
2024-10-16 Eingeleitet Scotiabank Sector Outperform
2024-04-02 Eingeleitet Goldman Neutral
2023-10-24 Eingeleitet Cantor Fitzgerald Overweight
2023-02-01 Eingeleitet Morgan Stanley Overweight
2022-11-08 Eingeleitet Canaccord Genuity Buy
2022-11-01 Eingeleitet BTIG Research Buy
2022-07-08 Eingeleitet Raymond James Outperform
2021-10-20 Fortgesetzt Cowen Outperform
2021-03-02 Eingeleitet Stifel Buy
2021-02-18 Eingeleitet Needham Buy
2020-12-16 Eingeleitet UBS Buy
2020-12-08 Herabstufung Oppenheimer Outperform → Perform
2020-07-02 Eingeleitet JP Morgan Overweight
2020-06-25 Fortgesetzt BofA/Merrill Buy
2020-06-01 Fortgesetzt Oppenheimer Outperform
2019-11-06 Eingeleitet Chardan Capital Markets Buy
2019-09-26 Eingeleitet Piper Jaffray Overweight
2019-04-23 Eingeleitet Robert W. Baird Outperform
2019-03-15 Eingeleitet BofA/Merrill Buy
2019-02-05 Eingeleitet Oppenheimer Outperform
2018-09-13 Eingeleitet Ladenburg Thalmann Buy
2018-07-10 Eingeleitet William Blair Outperform
Alle ansehen

Rocket Pharmaceuticals Inc Aktie (RCKT) Neueste Nachrichten

pulisher
08:09 AM

Rocket Pharmaceuticals Inc (RCKT)’s Market Momentum: Closing Strong at 7.16, Down -0.97 - DWinneX

08:09 AM
pulisher
07:41 AM

Rocket Pharmaceuticals Inc (RCKT) stock analysis: A simple moving average approach - uspostnews.com

07:41 AM
pulisher
Apr 28, 2025

Rocket Pharmaceuticals Inc [RCKT] Insider Activity: An Update for Investors - knoxdaily.com

Apr 28, 2025
pulisher
Apr 28, 2025

Is Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Stock Worth Investing In for High Returns? - Marketing Sentinel

Apr 28, 2025
pulisher
Apr 25, 2025

Rocket Pharmaceuticals appoints new board member - MSN

Apr 25, 2025
pulisher
Apr 25, 2025

RCKT stock touches 52-week low at $10.11 amid market challenges - MSN

Apr 25, 2025
pulisher
Apr 25, 2025

RCKT stock touches 52-week low at $9.76 amid market challenges - MSN

Apr 25, 2025
pulisher
Apr 24, 2025

Rocket Pharmaceuticals Inc (NASDAQ:RCKT) Could Actually Go To 39 In 12 Months - Marketing Sentinel

Apr 24, 2025
pulisher
Apr 23, 2025

Understanding the Risks of Investing in Rocket Pharmaceuticals Inc (RCKT) - knoxdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

Financial Metrics Exploration: Understanding Rocket Pharmaceuticals Inc (RCKT) Through Ratios - DWinneX

Apr 23, 2025
pulisher
Apr 22, 2025

The Future of Rocket Pharmaceuticals Inc: Analyzing RCKT - investchronicle.com

Apr 22, 2025
pulisher
Apr 22, 2025

Rocket Pharmaceuticals Inc [RCKT] Revenue clocked in at $0.00 million, down -42.96% YTD: What’s Next? - dbtnews.com

Apr 22, 2025
pulisher
Apr 21, 2025

Our Attention Has Been Attracted to Rocket Pharmaceuticals Inc (NASDAQ:RCKT) - uspostnews.com

Apr 21, 2025
pulisher
Apr 20, 2025

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Sold by Alliancebernstein L.P. - Defense World

Apr 20, 2025
pulisher
Apr 19, 2025

Geode Capital Management LLC Increases Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Apr 19, 2025
pulisher
Apr 18, 2025

(RCKT) Trading Report - news.stocktradersdaily.com

Apr 18, 2025
pulisher
Apr 18, 2025

JPMorgan Chase & Co. Sells 41,024 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Apr 18, 2025
pulisher
Apr 16, 2025

3 Stocks Insiders Are Buying Rapidly Amid Market Volatility - Investing.com

Apr 16, 2025
pulisher
Apr 16, 2025

Is Rocket Pharmaceuticals (NASDAQ:RCKT) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

Apr 16, 2025
pulisher
Apr 16, 2025

Countdown To Approval: Rocket Pharma's Gene Therapy For Rare Disease Awaits FDA Decision - RTTNews

Apr 16, 2025
pulisher
Apr 16, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Gap Up After Insider Buying Activity - Defense World

Apr 16, 2025
pulisher
Apr 15, 2025

Rocket Pharmaceuticals CEO buys $101.6K in common stock - MSN

Apr 15, 2025
pulisher
Apr 14, 2025

Rocket Pharmaceuticals CEO Gaurav Shah acquires $101,600 in stock By Investing.com - Investing.com India

Apr 14, 2025
pulisher
Apr 14, 2025

Rocket Pharmaceuticals CEO Gaurav Shah acquires $101,600 in stock - Investing.com Australia

Apr 14, 2025
pulisher
Apr 14, 2025

If You Don’t Buy Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Now, You’ll Kick Yourself Later - stocksregister.com

Apr 14, 2025
pulisher
Apr 11, 2025

Raymond James Financial Inc. Makes New $285,000 Investment in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Apr 11, 2025
pulisher
Apr 11, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT) Earns Buy Rating from Needham & Company LLC - Defense World

Apr 11, 2025
pulisher
Apr 10, 2025

Rocket Pharmaceuticals executive Kinnari Patel buys $99,165 in stock By Investing.com - Investing.com South Africa

Apr 10, 2025
pulisher
Apr 10, 2025

Rocket Pharmaceuticals executive Kinnari Patel buys $99,165 in stock - Investing.com

Apr 10, 2025
pulisher
Apr 10, 2025

Rocket Pharma Out Of Orbit, But Ready For Re-Launch (NASDAQ:RCKT) - Seeking Alpha

Apr 10, 2025
pulisher
Apr 10, 2025

The Escalator: Rocket Pharmaceuticals, Zenas BioPharma, Angelini Ventures - Medical Marketing and Media

Apr 10, 2025
pulisher
Apr 10, 2025

Corebridge Financial Inc. Sells 2,469 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Apr 10, 2025
pulisher
Apr 10, 2025

Vanguard Group Inc. Purchases 1,040,655 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Apr 10, 2025
pulisher
Apr 09, 2025

Rocket Pharmaceuticals (RCKT): Among Stocks Under $10 that Will Triple - Insider Monkey

Apr 09, 2025
pulisher
Apr 09, 2025

KLP Kapitalforvaltning AS Buys Shares of 15,300 Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Apr 09, 2025
pulisher
Apr 08, 2025

Rocket Pharmaceuticals CFO sells $39,646 in stock By Investing.com - Investing.com India

Apr 08, 2025
pulisher
Apr 08, 2025

Rocket Pharmaceuticals CFO sells $39,646 in stock - Investing.com

Apr 08, 2025
pulisher
Apr 08, 2025

Rocket Pharmaceuticals CFO Sells Shares to Cover Tax Obligations - TradingView

Apr 08, 2025
pulisher
Apr 08, 2025

10 Stocks Under $10 that Will Triple - Insider Monkey

Apr 08, 2025
pulisher
Apr 08, 2025

BMO maintains Rocket Pharmaceuticals Outperform rating By Investing.com - Investing.com UK

Apr 08, 2025
pulisher
Apr 08, 2025

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Apr 08, 2025
pulisher
Apr 07, 2025

Rocket Pharmaceuticals appoints new Chief Officer By Investing.com - Investing.com Canada

Apr 07, 2025
pulisher
Apr 07, 2025

Rocket Pharmaceuticals appoints new Chief Officer - Investing.com Australia

Apr 07, 2025
pulisher
Apr 03, 2025

Rocket Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference - BioSpace

Apr 03, 2025
pulisher
Apr 03, 2025

Genetic Therapy Breakthroughs: Rocket Pharma CEO Set to Reveal Strategic Updates at Major Healthcare Conference - Stock Titan

Apr 03, 2025
pulisher
Apr 03, 2025

Thrivent Financial for Lutherans Sells 21,731 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Apr 03, 2025
pulisher
Apr 03, 2025

RCKT stock plunges to 52-week low, hitting $5.68 - Investing.com

Apr 03, 2025
pulisher
Apr 02, 2025

Is Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) the Best US Stock Under $10 to Buy Right Now? - MSN

Apr 02, 2025
pulisher
Apr 02, 2025

Where are the Opportunities in (RCKT) - news.stocktradersdaily.com

Apr 02, 2025
pulisher
Apr 02, 2025

Teacher Retirement System of Texas Raises Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Apr 02, 2025
pulisher
Mar 30, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT) Reaches New 1-Year LowHere's Why - MarketBeat

Mar 30, 2025

Finanzdaten der Rocket Pharmaceuticals Inc-Aktie (RCKT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.90
price up icon 1.36%
$69.80
price up icon 0.31%
$32.42
price down icon 0.60%
$24.00
price up icon 0.25%
$103.85
price down icon 0.51%
biotechnology ONC
$249.09
price down icon 0.47%
Kapitalisierung:     |  Volumen (24h):